Fate of Endogenous Stem/progenitor Cells Following Spinal Cord Injury
Overview
Affiliations
The adult mammalian spinal cord contains neural stem and/or progenitor cells that slowly multiply throughout life and differentiate exclusively into glia. The contribution of adult progenitors to repair has been highlighted in recent studies, demonstrating extensive cell proliferation and gliogenesis following central nervous system (CNS) trauma. The present experiments aimed to determine the relative roles of endogenously dividing progenitor cells versus quiescent progenitor cells in posttraumatic gliogenesis. Using the mitotic indicator bromodeoxyuridine (BrdU) and a retroviral vector, we found that, in the adult female Fisher 344 rat, endogenously dividing neural progenitors are acutely vulnerable in response to T8 dorsal hemisection spinal cord injury. We then studied the population of cells that divide postinjury in the injury epicenter by delivering BrdU or retrovirus at 24 hours after spinal cord injury. Animals were euthanized at five timepoints postinjury, ranging from 6 hours to 9 weeks after BrdU delivery. At all timepoints, we observed extensive proliferation of ependymal and periependymal cells that immunohistochemically resembled stem/progenitor cells. BrdU+ incorporation was noted to be prominent in NG2-immunoreactive progenitors that matured into oligodendrocytes, and in a transient population of microglia. Using a green fluorescence protein (GFP) hematopoietic chimeric mouse, we determined that 90% of the dividing cells in this early proliferation event originate from the spinal cord, whereas only 10% originate from the bone marrow. Our results suggest that dividing, NG2-expressing progenitor cells are vulnerable to injury, but a separate, immature population of neural stem and/or progenitor cells is activated by injury and rapidly divides to replace this vulnerable population.
Unraveling the role of oligodendrocytes and myelin in pain.
Kim W, Angulo M J Neurochem. 2024; 169(1):e16206.
PMID: 39162089 PMC: 11657919. DOI: 10.1111/jnc.16206.
Nekanti U, Sakthivel P, Zahedi A, Creasman D, Nishi R, Dumont C NPJ Regen Med. 2024; 9(1):12.
PMID: 38499577 PMC: 10948859. DOI: 10.1038/s41536-024-00356-0.
Liu Y, Luo Z, Xie Y, Sun Y, Yuan F, Jiang L Cell Commun Signal. 2024; 22(1):155.
PMID: 38424563 PMC: 10903014. DOI: 10.1186/s12964-023-01434-4.
He K, Yu H, Zhang J, Wu L, Han D, Ma R Front Neurol. 2024; 14:1280908.
PMID: 38249747 PMC: 10797099. DOI: 10.3389/fneur.2023.1280908.
In vivo cell fate reprogramming for spinal cord repair.
Tai W, Zhang C Curr Opin Genet Dev. 2023; 82:102090.
PMID: 37506560 PMC: 11025462. DOI: 10.1016/j.gde.2023.102090.